Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations

被引:2
|
作者
Zhang, Ye [1 ,2 ,3 ,4 ,5 ]
Zhou, Zheng [1 ,2 ,3 ,4 ,5 ]
Liu, Xiaoxiao [1 ,2 ,3 ,4 ,5 ]
Zhu, Lijing [1 ,2 ,3 ,4 ,5 ]
Cui, Yajuan [1 ,2 ,3 ,4 ,5 ]
Li, Tie-jun [1 ,2 ,3 ,4 ,5 ]
Zhou, Chuan-Xiang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Peking Univ, Sch & Hosp Stomatol, Dept Oral Pathol, Beijing 100081, Peoples R China
[2] Natl Ctr Stomatol, Beijing, Peoples R China
[3] Natl Clin Res Ctr Oral Dis, Beijing, Peoples R China
[4] Natl Engn Res Ctr Oral Biomat & Digital Med Device, Beijing, Peoples R China
[5] Chinese Acad Med Sci 2019RU034, Res Unit Precis Pathol Diag Tumors Oral & Maxillof, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
salivary mucinous adenocarcinoma; colloid carcinoma; papillary carcinoma; AKT1 E17K mutation; BRAF V600E mutation; CARCINOMA;
D O I
10.1097/PAS.0000000000002164
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The relationship between various patterns of mucin-producing salivary adenocarcinomas, including invasive salivary adenocarcinomas with mucinous differentiation, such as colloid and papillary carcinomas, remains unclear. Herein, we aimed to describe the clinicopathologic characteristics, immunophenotypes, molecular underpinnings, and clinical behavior of salivary mucinous adenocarcinomas (MA) to clarify their classification. We described a broad series of colloid and papillary patterns of MAs, indicating that papillary pattern presented papillary cystic proliferation of mucinous columnar cells as salivary intraductal papillary mucinous neoplasms with recurrent AKT1 E17K mutations, whereas colloid adenocarcinomas containing large mucinous pools or lakes around the malignant epithelial nests or islands harbored BRAF V600E mutations with worse prognosis. Typical morphologic structures, CK7(+), CK20(-), CDX2(-), p63(-), p40(-), MAML2 fluorescence in situ hybridization (-), AR(-), TTF-1(-), S100(-), mammaglobin(-), or S100/mammaglobin(+) with ETV6 fluorescence in situ hybridization (-) immunophenotype, and recurrent AKT1 E17K or BRAF V600E mutations may be defined. To our knowledge, this small series represents the first genetic study on a typical colloid pattern of MA, and our study with the spectrum documentation for MA in clinicopathologic characteristics, histologic and immunophenotypes, molecular features, and clinical behavior will allow for a better understanding of these rare but distinctive tumors.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 50 条
  • [41] Detection of BRAF V600E mutation by pyrosequencing
    Tan, Yi Hui
    Liu, Yanqun
    Eu, Kong Weng
    Ang, Pei Woon
    Li, Wei Qi
    Salto-Tellez, Manuel
    Iacopetta, Barry
    Soong, Richie
    PATHOLOGY, 2008, 40 (03) : 295 - 298
  • [42] BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
    Dias-Santagata, Dora
    Lam, Quynh
    Vernovsky, Kathy
    Vena, Natalie
    Lennerz, Jochen K.
    Borger, Darrell R.
    Batchelor, Tracy T.
    Ligon, Keith L.
    Iafrate, A. John
    Ligon, Azra H.
    Louis, David N.
    Santagata, Sandro
    PLOS ONE, 2011, 6 (03):
  • [43] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    LABORATORY INVESTIGATION, 2014, 94 : 173A - 173A
  • [44] Absence of the BRAF V600E mutation in pheochromocytoma
    Johan O. Paulsson
    F. Svahn
    J. Welander
    L. Brunaud
    P. Söderkvist
    O. Gimm
    A. Stenman
    C. C. Juhlin
    Journal of Endocrinological Investigation, 2016, 39 : 715 - 716
  • [45] Absence of the BRAF V600E mutation in pheochromocytoma
    Paulsson, Johan O.
    Svahn, F.
    Welander, J.
    Brunaud, L.
    Soderkvist, P.
    Gimm, O.
    Stenman, A.
    Juhlin, C. C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (06): : 715 - 716
  • [46] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
  • [47] BRAF V600E is not a consistent feature of myopericytoma
    Mito, Jeffrey K.
    Jo, Vickie Y.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (12) : 1248 - 1249
  • [48] BRAF V600E MUTATION IN PEDIATRIC ASTROBLASTOMAS
    Antonelli, Manila
    Nizza, Paolo
    Gardiman, Marina P.
    Buttarelli, Francesca R.
    Cerati, Michele
    Milanaccio, Claudia
    Coli, Antonella
    Massimino, Maura
    Pollo, Bianca
    Moi, Loredana
    Badiali, Manuela
    Giangaspero, Felice
    NEURO-ONCOLOGY, 2016, 18 : 50 - 50
  • [49] Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (07): : 234 - 235
  • [50] Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis
    H. Hägglund
    B. Sander
    A. Ahmadi
    T. Gülen
    G. Nilsson
    Medical Oncology, 2014, 31